Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

InMed Pharmaceuticals' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.37 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 27.95% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, down 27.95%, while the annual FY2025 figure was 0.36, 1.72% up from the prior year.
  • Asset Utilization Ratio reached 0.37 in Q4 2025 per INM's latest filing, up from 0.33 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.55 in Q1 2025 to a low of 0.08 in Q2 2022.
  • Average Asset Utilization Ratio over 4 years is 0.33, with a median of 0.37 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 308.98% in 2023, then decreased 27.95% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then surged by 308.98% to 0.42 in 2023, then increased by 21.52% to 0.51 in 2024, then fell by 27.95% to 0.37 in 2025.
  • Per Business Quant, the three most recent readings for INM's Asset Utilization Ratio are 0.37 (Q4 2025), 0.33 (Q3 2025), and 0.4 (Q2 2025).